|
CYP2C19 induction assay
|
BAO_0010152 |
|
|
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
|
CHEBI_77402 |
|
|
CYP2B6 induction assay
|
BAO_0010151 |
|
|
tricuspid valve insufficiency
|
DOID_4080 |
|
|
monoamine oxidase inhibition assay
|
BAO_0010158 |
|
|
pancreatic cystadenocarcinoma
|
DOID_4073 |
|
|
incretin mimetic
|
CHEBI_64088 |
|
|
tricuspid valve stenosis
|
DOID_4078 |
|
|
beta-adrenergic agonist
|
CHEBI_35522 |
|
|
bronchodilator agent
|
CHEBI_35523 |
|
|
sympathomimetic agent
|
CHEBI_35524 |
|
|
neuroendocrine carcinoma
|
DOID_1800 |
|
|
renal excretion assay
|
BAO_0010143 |
|
|
mass balance assay
|
BAO_0010140 |
|
|
human mammary epithelial cell permeability assay
|
BAO_0010142 |
|
|
Fc/FcRN induction assay
|
BAO_0010145 |
|
|
receptor induction assay
|
BAO_0010144 |
|
|
biliary excretion assay
|
BAO_0010141 |
|
|
CYP induction screen
|
BAO_0010147 |
|
|
enzyme induction assay
|
BAO_0010146 |
|
